Dow Up 0.15% Nasdaq Up 0.21%

More On GNMSF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Genmab A/S (GNMSF)

-Other OTC
40.85 Sep 12, 9:32AM EDT
|Pre-Market : NaN
Prev Close:40.85
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:36.50 - 46.72
Volume:0
Avg Vol (3m):145
Market Cap:2.32B
P/E (ttm):86.00
EPS (ttm):0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GNMSF

Key Statistics

Forward P/E (1 yr):11.44
P/S (ttm):18.25
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :4.10
Quarterly EPS Est (Sep-14) :1.35
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Genmab A/S, a biotechnology company, develops human antibody therapeutics for the treatment of cancer in Denmark, the Netherlands, the United States, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback